Evidence supporting that Src blockade targets CSC subpopulation was highlighted as a dual MEK and Src inhibitor decreased the ALDH1+ population, and reduced sphere-forming and tumor-initiating cells in tumor xenografts [64]. Here, ALDH1A1 is linked to neoplasm.